Frontiers in Pediatrics (Mar 2023)

Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases

  • Laura Räisänen,
  • Heli Viljakainen,
  • Heli Viljakainen,
  • Kaija-Leena Kolho,
  • Kaija-Leena Kolho

DOI
https://doi.org/10.3389/fped.2023.1157547
Journal volume & issue
Vol. 11

Abstract

Read online

Proton pump inhibitors (PPIs) have been associated with decreased gut microbiota diversity. Disrupted gut microbiota composition has been reported in several autoimmune diseases (ADs), such as type 1 diabetes mellitus (DM), autoimmune thyroiditis (AIT), juvenile idiopathic arthritis (JIA), and inflammatory bowel diseases (IBD). We investigated whether PPIs are associated with the development of ADs in children and concluded that PPI exposures could be related to the onset of ADs, especially IBD and potentially AIT as well.

Keywords